GeNeuro Aktie
| 0,04EUR | 0,00EUR | -4,76% |
WKN DE: A2AHDP / ISIN: CH0308403085
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 17 | 17 | 20 | 19 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 7 | 8 | 10 | 9 | 2 |
| Summe Anlagevermögen | 2 | 3 | 3 | 2 | 4 |
| Summe Aktiva | 9 | 10 | 12 | 11 | 6 |
Bilanz (in Mio. EUR) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 15 | 5 | 8 | 10 | 20 |
| Summe Eigenkapital | -5 | 5 | 5 | 1 | -14 |
| Summe Passiva | 9 | 10 | 12 | 11 | 6 |
Adresse
| 3, chemin du Pré-Fleur, 1228 Plan-les-Ouates | |
| Telefon | +41 (22) 552-48-00 |
| Fax | +41 (22) 794-50-86 |
| Internet | http://www.geneuro.ch |
Management
|
Alois B. Lang
Chief Development Officer |
|
Anke Post
Chief Medical Officer |
|
Giacomo di Nepi
Independent Director |
|
Gordon S. Francis
Independent Director |
|
Hedi Ben Brahim
Independent Director |
|
Hervé Perron
Chief Scientific Officer |
|
Jesús Martin-Garcia
Chairman & Chief Executive Officer |
|
Michel Dubois
Independent Director |
|
Miguel Payró
Chief Financial Officer & Head-Human Resources |
|
Pascal Lemaire
Director |
|
Philippe Archinard
Independent Director |
|
Sandrine Flory
Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.